212 related articles for article (PubMed ID: 29846236)
21. Chelation therapy for atherosclerotic cardiovascular disease.
Villarruz MV; Dans A; Tan F
Cochrane Database Syst Rev; 2002; (4):CD002785. PubMed ID: 12519577
[TBL] [Abstract][Full Text] [Related]
22. EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.
Born T; Kontoghiorghe CN; Spyrou A; Kolnagou A; Kontoghiorghes GJ
Toxicol Mech Methods; 2013 Jan; 23(1):11-7. PubMed ID: 22991933
[TBL] [Abstract][Full Text] [Related]
23. The protection conferred by chelation therapy in post-MI diabetics might be replicated by high-dose zinc supplementation.
McCarty MF; DiNicolantonio JJ
Med Hypotheses; 2015 May; 84(5):451-5. PubMed ID: 25682188
[TBL] [Abstract][Full Text] [Related]
24. Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.
Mathew RO; Schulman-Marcus J; Nichols EL; Newman JD; Bangalore S; Farkouh M; Sidhu MS
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):619-625. PubMed ID: 29129003
[TBL] [Abstract][Full Text] [Related]
25. Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment.
Bañeras J; Iglesies-Grau J; Téllez-Plaza M; Arrarte V; Báez-Ferrer N; Benito B; Campuzano Ruiz R; Cecconi A; Domínguez-Rodríguez A; Rodríguez-Sinovas A; Ujueta F; Vozzi C; Lamas GA; Navas-Acién A
Rev Esp Cardiol (Engl Ed); 2022 Dec; 75(12):1050-1058. PubMed ID: 35931285
[TBL] [Abstract][Full Text] [Related]
26. Evaluation on curative effects of ethylene diamine tetra-acetic acid chelation therapy in treating with atherosclerotic cardiovascular disease: A protocol for systematic review and meta-analysis.
Song T; Zhang D
Medicine (Baltimore); 2020 Dec; 99(52):e23346. PubMed ID: 33350725
[TBL] [Abstract][Full Text] [Related]
27. Design of the Trial to Assess Chelation Therapy (TACT).
Lamas GA; Goertz C; Boineau R; Mark DB; Rozema T; Nahin RL; Drisko JA; Lee KL
Am Heart J; 2012 Jan; 163(1):7-12. PubMed ID: 22172430
[TBL] [Abstract][Full Text] [Related]
28. From the National Heart, Lung, and Blood Institute (NHLBI): EDTA chelation therapy modestly reduces cardiovascular events.
National Heart, Lung, and Blood Institute
Ethn Dis; 2013; 23(3):388. PubMed ID: 23914432
[No Abstract] [Full Text] [Related]
29. EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.
Lamas GA; Boineau R; Goertz C; Mark DB; Rosenberg Y; Stylianou M; Rozema T; Nahin RL; Terry Chappell L; Lindblad L; Lewis EF; Drisko J; Lee KL
Am Heart J; 2014 Jul; 168(1):37-44.e5. PubMed ID: 24952858
[TBL] [Abstract][Full Text] [Related]
30. Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT).
Issa OM; Roberts R; Mark DB; Boineau R; Goertz C; Rosenberg Y; Lewis EF; Guarneri E; Drisko J; Magaziner A; Lee KL; Lamas GA
Am Heart J; 2018 Jan; 195():70-77. PubMed ID: 29224648
[TBL] [Abstract][Full Text] [Related]
31. Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial.
Mark DB; Anstrom KJ; Clapp-Channing NE; Knight JD; Boineau R; Goertz C; Rozema TC; Liu DM; Nahin RL; Rosenberg Y; Drisko J; Lee KL; Lamas GA;
Circ Cardiovasc Qual Outcomes; 2014 Jul; 7(4):508-16. PubMed ID: 24987051
[TBL] [Abstract][Full Text] [Related]
32. EDTA chelation therapy for cardiovascular disease: a systematic review.
Seely DM; Wu P; Mills EJ
BMC Cardiovasc Disord; 2005 Nov; 5():32. PubMed ID: 16262904
[TBL] [Abstract][Full Text] [Related]
33. Alternative medicine. NIH trial to test chelation therapy.
Holden C
Science; 2002 Aug; 297(5584):1109. PubMed ID: 12183605
[No Abstract] [Full Text] [Related]
34. Low-Level Metal Contamination and Chelation in Cardiovascular Disease-A Ripe Area for Toxicology Research.
Ujueta F; Navas-Acien A; Mann KK; Prashad R; Lamas GA
Toxicol Sci; 2021 May; 181(2):135-147. PubMed ID: 33662137
[TBL] [Abstract][Full Text] [Related]
35. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
[TBL] [Abstract][Full Text] [Related]
36. Low-Level Cadmium Exposure and Atherosclerosis.
Diaz D; Ujueta F; Mansur G; Lamas GA; Navas-Acien A; Arenas IA
Curr Environ Health Rep; 2021 Mar; 8(1):42-53. PubMed ID: 33754286
[TBL] [Abstract][Full Text] [Related]
37. Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract.
Zhang M; Shoeb M; Liu P; Xiao T; Hogan D; Wong IG; Campbell GA; Ansari NH
J Toxicol Environ Health A; 2011; 74(6):380-91. PubMed ID: 21271438
[TBL] [Abstract][Full Text] [Related]
38. Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings.
Alam ZH; Ujueta F; Arenas IA; Nigra AE; Navas-Acien A; Lamas GA
Int J Environ Res Public Health; 2020 Jun; 17(13):. PubMed ID: 32610666
[TBL] [Abstract][Full Text] [Related]
39. Chelation-therapy heart trial draws fire.
Callaway E
Nature; 2012 Nov; 491(7424):313-5. PubMed ID: 23151555
[No Abstract] [Full Text] [Related]
40. Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasma.
Frizzell N; Baynes JW
Clin Chem Lab Med; 2014 Jan; 52(1):69-75. PubMed ID: 23612664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
